According to Sonoma Pharmaceuticals's latest financial reports the company's total debt is $0.38 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-03-31 | $0.84 M | -37.89% |
2022-03-31 | $1.36 M | -48.9% |
2021-03-31 | $2.67 M | 214.71% |
2020-03-31 | $0.85 M | 78.95% |
2019-03-31 | $0.47 M | -14.1% |
2018-03-31 | $0.55 M | 34.88% |
2017-03-31 | $0.41 M | 259.65% |
2016-03-31 | $0.11 M | 31.03% |
2015-03-31 | $0.08 M | -40.82% |
2014-03-31 | $0.14 M | -92.4% |
2013-03-31 | $1.93 M | -40.26% |
2012-03-31 | $3.23 M | 27.27% |
2011-03-31 | $2.54 M | 710.51% |
2010-03-31 | $0.31 M | -6.27% |
2009-03-31 | $0.33 M | -84.94% |
2008-03-31 | $2.22 M | -72.47% |
2007-03-31 | $8.07 M | 948.96% |
2006-03-31 | $0.77 M | -48.56% |
2005-03-31 | $1.49 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.32 B | 84,721.82% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | N/A | N/A | ๐บ๐ธ USA |